First Anionic Cathelicidin Discovered: Fights Inflammation and Heals Wounds Without Antimicrobial Activity

The first-ever anionic cathelicidin (TK-CATH) from salamander skin lacks direct antimicrobial activity but shows potent anti-inflammatory and wound healing effects, accelerating skin repair in mice through MAPK pathway inhibition.

Luo, Xuanjin et al.·Biochimie·2021·Moderate Evidenceanimal study
RPEP-05570Animal studyModerate Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
animal study
Evidence
Moderate Evidence
Sample
N=N/A (animal study, group sizes not specified)
Participants
Salamander (T. kweichowensis) skin; amphibian leukocytes; mouse macrophages; mouse wound model

What This Study Found

TK-CATH: first anionic cathelicidin (net charge -3). No direct antimicrobial activity. Potent anti-inflammatory (inhibited LPS-induced cytokines via MAPK). Promoted wound healing: cytokines, chemokines, growth factors, keratinocyte motility/proliferation, and accelerated full-thickness wound repair in mice.

Key Numbers

Net charge -3; inhibits MAPK signaling; promotes keratinocyte motility/proliferation; accelerated full-thickness wound healing in mice

How They Did This

Discovery and characterization study. TK-CATH identified from T. kweichowensis salamander skin. Anti-inflammatory testing in amphibian leukocytes and mouse macrophages. MAPK pathway analysis. Wound healing: keratinocyte assays and mouse full-thickness wound model. Free radical scavenging and cytotoxicity assessment.

Why This Research Matters

Discovering a cathelicidin that heals wounds without killing bacteria changes how we think about antimicrobial peptides. It suggests the cathelicidin family evolved specialized members for tissue repair, not just pathogen defense — with direct therapeutic implications.

The Bigger Picture

This fundamentally expands the cathelicidin concept: from "antimicrobial peptides" to "host defense and repair peptides." Anionic cathelicidins specialized for wound healing could exist in other species including humans, potentially undiscovered.

What This Study Doesn't Tell Us

Salamander peptide — may not directly translate to human therapy. TK-CATH would need modification for human therapeutic use. Mouse wound model is relatively simple. Mechanism of wound healing beyond cytokine induction not fully detailed.

Questions This Raises

  • ?Do undiscovered anionic cathelicidins exist in the human genome?
  • ?Could TK-CATH-inspired peptides be developed as wound healing drugs?
  • ?Why did this cathelicidin evolve to lose antimicrobial activity but gain wound healing function?

Trust & Context

Key Stat:
First anionic member All cathelicidins were cationic bacteria-killers — until TK-CATH, the first anionic member that specializes in inflammation control and wound repair instead
Evidence Grade:
Moderate evidence: first discovery supported by in vitro mechanism elucidation and in vivo wound healing in mouse model.
Study Age:
Published 2021. This paradigm-shifting discovery may lead to searches for anionic cathelicidins in other species.
Original Title:
A novel anionic cathelicidin lacking direct antimicrobial activity but with potent anti-inflammatory and wound healing activities from the salamander Tylototriton kweichowensis.
Published In:
Biochimie, 191, 37-50 (2021)
Database ID:
RPEP-05570

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Why is an anionic cathelicidin surprising?

All previously known cathelicidins carry positive charges, which is how they interact with and destroy negatively charged bacterial membranes. Finding one with negative charges that doesn't kill bacteria — but instead heals wounds — completely changes our understanding of this peptide family.

Could this help heal human wounds?

TK-CATH accelerated wound healing in mice by reducing inflammation and promoting tissue repair. While it's from a salamander, its mechanism (MAPK inhibition + growth factor induction) works in mammalian cells, suggesting it could inspire human wound healing peptide drugs.

Read More on RethinkPeptides

Cite This Study

RPEP-05570·https://rethinkpeptides.com/research/RPEP-05570

APA

Luo, Xuanjin; Ouyang, Jianhong; Wang, Yan; Zhang, Minghui; Fu, Lei; Xiao, Ning; Gao, Lianghui; Zhang, Peng; Zhou, Jiang; Wang, Yipeng. (2021). A novel anionic cathelicidin lacking direct antimicrobial activity but with potent anti-inflammatory and wound healing activities from the salamander Tylototriton kweichowensis.. Biochimie, 191, 37-50. https://doi.org/10.1016/j.biochi.2021.08.007

MLA

Luo, Xuanjin, et al. "A novel anionic cathelicidin lacking direct antimicrobial activity but with potent anti-inflammatory and wound healing activities from the salamander Tylototriton kweichowensis.." Biochimie, 2021. https://doi.org/10.1016/j.biochi.2021.08.007

RethinkPeptides

RethinkPeptides Research Database. "A novel anionic cathelicidin lacking direct antimicrobial ac..." RPEP-05570. Retrieved from https://rethinkpeptides.com/research/luo-2021-a-novel-anionic-cathelicidin

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.